Disease | cerebral hemorrhage |
Phenotype | C0019204|hepatocellular carcinoma |
Sentences | 1 |
PubMedID- 20028762 | Purpose: patients with central nervous system (cns) metastases were excluded from bevacizumab trials following a case of fatal cerebral hemorrhage in a patient with hepatocellular carcinoma in 1997. |
Page: 1